TARPLIN, DOWNS & YOUNG, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
- orphan drug tax credit H.R. 3678 - Preserving Access to Orphan Drug Act of 2015 S. 1906/H.R. 3618 - Orphan Drug Fairness Act
Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| JENNIFER B YOUNG | — |
Copyright/Patent/Trademark CPT
H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act
Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| JENNIFER B YOUNG | — |
Health Issues HCR
Health care reform, drug importation, 340b, biosimilars PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 6 - 21st Century Cures Innovation For Healthier Americans S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 1878 - Advancing Hope Act S. 2912 - Right to Try Act ***no specific bills, importation, Prescription Drug User Fee Act Renewal and associated policies, supply chain integrity, user fee sequester, Innovation
Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
PL 111-148 - The Patient Protection and Affordable Care Act, implementation, ESRD, clinical laboratory payment H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 1470/S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 Part B demonstration H.R. 5122 - Part B demonstration H.R. 34 - 21st Century Cures Act ***, no specific bill(s), Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, MS, Infusion, oncology, CMMI S. 275/H.R. 609 - Home Infusion Site of Care Act
Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin |
| CHARLOTTE SPEARS IVANCIC | Legislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John Boehner |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance |
Budget/Appropriations BUD
budget resolution, reconciliation, deficit reduction, debt ceiling, apropriations H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 H.R. 5325 - Continuing Appropriations H.R. 2028 - Further Continuing and Security Assistance Appropriations Act, 2017
Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.